What other stocks do shareholders of Santarus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Santarus investors own include Baidu (BIDU) , Home Depot (HD) , Pharmacyclics (PCYC) , Yelp (YELP) , ACADIA Pharmaceuticals (Acad) , Altaba (AABA) , Allergan (AGN) , Alexion Pharmaceuticals (ALXN) and Cree (CREE) .

NASDAQ:SNTS

Santarus (SNTS) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free SNTS Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: $16,995.00
▼
$16,995.00
52-Week Range: N/A

Volume: 54,432 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Santarus alerts:

Ad Crypto Swap Profits

He Is Giving Away Bitcoin

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Santarus Stock (NASDAQ:SNTS)

Santarus, Inc. (Santarus) is a specialty biopharmaceutical company focused on acquiring, developing and commercializing products that address the needs of patients treated by physician specialists. As of December 31, 2012, the Company’s marketed and approved products included Uceris (budesonide), Zegerid (omeprazole/sodium bicarbonate), Glumetza (metformin hydrochloride extended release tablets), Cycloset (bromocriptine mesylate) tablets and Fenoglide (fenofibrate) tablets. As of December 31, 2012, the Company’s investigational drugs included Ruconest (recombinant human C1 esterase inhibitor), Rifamycin SV MMX, and SAN-300 (anti-VLA-1 antibody). In January 2014, Salix Pharmaceuticals, Ltd. acquired Santarus, Inc.

Ad Crypto Swap Profits

He Is Giving Away Bitcoin

>> Register right here

SNTS Stock News Headlines

February 23, 2024 | morningstar.com

Societe Nationale des Telecommunications SONATEL SNTS

December 30, 2023 | mirror.co.uk

Ant McPartlin and wife Anne-Marie beam as they jet off to Dubai for plush New Year holiday

April 19, 2024 | Stansberry Research (Ad)

The "Smart Money" Is Ready for May 1st Are You?

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

December 18, 2023 | bbc.com

Jack Ma's Ant Group: World's biggest market debut suspended

October 12, 2023 | thestreet.com

Biotech Stock Mailbag: Cardium Therapeutics

July 27, 2023 | investing.com

Societe Nationale des Telecommunications du Senegal (SNTS)

May 25, 2023 | wsj.com

Societe Nationale de Telecommunications du Senegal

February 17, 2023 | duluthnewstribune.com

Saints report: Bostedt, CSS win their sixth straight in men’s hockey

April 19, 2024 | Stansberry Research (Ad)

The "Smart Money" Is Ready for May 1st Are You?

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

February 14, 2023 | duluthnewstribune.com

Saints report: CSS earn MIAC men’s hockey sweep of Cobbers

February 14, 2023 | duluthnewstribune.com

Saints report: CSS men victorious at Augsburg

December 26, 2022 | thestreet.com

Santarus Stock Hits New 52-Week High (SNTS)

September 20, 2022 | usatoday.com

Tampa Bay Buccaneers at New Orleans Saints: Predictions, picks and odds for NFL Week 2 matchup

August 22, 2022 | thestreet.com

Cramer's 'Mad Money' Recap: The Knot Worth Tying

August 22, 2022 | thestreet.com

5 Stocks Insiders are Buying This Week

See More Headlines

Receive SNTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Santarus and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Pharmaceuticals
Current Symbol: NASDAQ:SNTS
CUSIP: 80281730
CIK: 1172480
Web: www.santarus.com
Phone: +1-858-3145700
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

SNTS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Santarus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Santarus investors own include Baidu (BIDU), Home Depot (HD), Pharmacyclics (PCYC), Yelp (YELP), ACADIA Pharmaceuticals (Acad), Altaba (AABA), Allergan (AGN), Alexion Pharmaceuticals (ALXN) and Cree (CREE).

This page (NASDAQ:SNTS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Santarus (SNTS) Stock Price, News & Analysis

About Santarus Stock (NASDAQ:SNTS)

SNTS Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

SNTS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info